Stay updated with breaking news from Vascular Closure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Haemonetics (NYSE: HAE) has been gaining from business growth within Plasma, Hospital and Hemostasis Management. Its new launches also aid growth. The stock carries a Zacks Rank #1 (Strong Buy) currently.
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better...
The global vascular closure device market is growing at a CAGR of 7.1% from 2022 to 2030.Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- A vascular closure device is a piece of collagen (a fibrous protein found in skin, connective tissue, and bone), a metallic clip, or a suture designed to close the small puncture produced in an artery following an angiography. According to our new research study on “Vascular Closure Device Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend
The vascular closure devices industry is in the midst of remarkable growth and transformation, evident both in its current market value and the expected trends. As of 2023, the market has surged to a valuation of approximately US$ 1,468.4 million, emphasizing the escalating demand for vascular closure devices.Lookin...
Haemonetics Corporation announced on October 10th that it would be acquiring OpSens, Inc. The deal between the companies is expected to close by the end of January 2024, according to...